Nifty

:

25030.35

Sensex

:

81028.02

493.75 (2.01%)
1718.01 (2.17%)

Login

Nifty
Sensex

:
:

25030.35
81028.02

493.75 (2.01%)
1718.01 (2.17%)

Bliss GVS Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

68/99

BSE: 506197 | NSE: BLISSGVS

Watchlist

NSE BSE

614.25

06-Nov-2026

Open
High
Low
Previous Close

626.1
635.8
613
632.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

76182
47146248.9
739.9
118

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,419.21
39.82
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,268.16
0.25%
4.97

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

1.51
4.40
6.37

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-3.02
4.75
-0.19

PAT CAGR (%)

10 Years
5 Years
3 Years

4.64
53.73
19.61

P:E (Median)

8 Years
5 Years
3 Years

16.59
17.29
17.31

P:BV (Average)

8 Years
5 Years
3 Years

1.75
1.61
2.02

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.62
8.45
10.28

Earnings Forecasts:

(Updated: 07-11-2026)

Description 2026 2027 2028 2029
Adj EPS 12.23 - - -
P/E Ratio 50.22 - - -
Revenue 927.11 - - -
EBITDA 164.04 - - -
Net Income 129.13 - - -
ROA 9.24 - - -
P/B Ratio 5.45 - - -
ROE 11.51 - - -
FCFF 84 - - -
FCFF Yield 1.27 - - -
Net Debt -146.57 - - -
BVPS 112.76 - - -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 261.13 190.22 37.28% 221.58 163.36 35.64% 211.54 156.00 35.60% 164.68 179.59 -8.30%
Expenses 200.69 159.95 25.47% 169.72 130.60 29.95% 167.39 142.27 17.66% 137.83 153.86 -10.42%
EBITDA 60.44 30.27 99.67% 51.87 32.77 58.29% 44.15 13.73 221.56% 26.85 25.73 4.35%
EBIDTM 23.14% 15.91% 23.41% 20.06% 20.87% 8.80% 16.30% 14.33%
Other Income 7.44 13.59 -45.25% 8.76 10.59 -17.28% 9.30 9.36 -0.64% 10.23 11.66 -12.26%
Interest 1.12 2.71 -58.67% 0.39 5.11 -92.37% 1.81 1.30 39.23% 1.48 0.67 120.90%
Depreciation 9.47 7.69 23.15% 9.03 7.68 17.58% 7.84 7.43 5.52% 7.80 6.96 12.07%
PBT 98.37 33.45 194.08% 51.21 30.56 67.57% 44.15 14.36 207.45% 25.29 29.77 -15.05%
Tax 24.80 8.66 186.37% 12.59 9.51 32.39% 11.73 2.91 303.09% 6.68 8.72 -23.39%
PAT 73.56 24.79 196.73% 38.62 21.05 83.47% 32.42 11.45 183.14% 18.61 21.05 -11.59%
PATM 28.17% 13.03% 17.43% 12.89% 15.33% 7.34% 11.30% 11.72%
EPS 6.92 2.33 197.00% 3.63 1.98 83.33% 3.05 1.08 182.41% 1.75 1.98 -11.62%

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 313.37 244.40 28.22% 285.58 207.47 37.65% 256.99 197.99 29.80% 218.25 210.42 3.72%
Expenses 232.78 200.92 15.86% 209.18 166.14 25.91% 212.55 176.90 20.15% 183.46 180.63 1.57%
EBITDA 80.58 43.48 85.33% 76.40 41.33 84.85% 44.44 21.09 110.72% 34.79 29.79 16.78%
EBIDTM 25.72% 17.79% 26.75% 19.92% 17.29% 10.65% 15.94% 14.16%
Other Income 8.30 8.46 -1.89% 9.60 35.45 -72.92% 11.16 12.07 -7.54% 18.46 15.27 20.89%
Interest 3.30 3.04 8.55% 0.58 5.47 -89.40% 2.01 1.68 19.64% 1.49 1.08 37.96%
Depreciation 10.50 8.26 27.12% 9.94 8.20 21.22% 8.67 8.04 7.84% 8.35 7.55 10.60%
PBT 75.10 40.63 84.84% 75.48 63.11 19.60% 44.95 23.44 91.77% 40.89 36.42 12.27%
Tax 21.76 12.04 80.73% 24.11 18.75 28.59% 7.95 6.79 17.08% 16.12 10.62 51.79%
PAT 53.34 28.59 86.57% 51.37 44.36 15.80% 37.00 16.65 122.22% 24.78 25.80 -3.95%
PATM 17.02% 11.70% 17.99% 21.38% 14.40% 8.41% 11.35% 12.26%
EPS 4.91 2.58 90.31% 4.72 4.08 15.69% 3.36 1.47 128.57% 2.20 2.26 -2.65%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 858.93 729.81 667.20 605.46 598.34 636.36 465.51 441.95 426.59 297.89 348.02 Net Sales Growth 24.63% 9.38% 10.20% 1.19% -5.97% 36.70% 5.33% 3.60% 43.20% -14.40% Cost Of Goods Sold 376.76 342.63 346.10 299.47 314.90 343.94 253.30 236.73 225.15 145.81 167.21 Gross Profit 482.17 387.17 321.10 305.99 283.44 292.41 212.21 205.23 201.44 152.08 180.80 GP Margin 56.14% 53.05% 48.13% 50.54% 47.37% 45.95% 45.59% 46.44% 47.22% 51.05% 51.95% Total Expenditure 675.63 610.58 575.62 498.29 508.18 527.16 374.05 341.78 333.49 209.43 247.49 Power & Fuel Cost - 12.95 9.76 8.81 5.80 7.09 6.99 4.70 3.57 2.59 2.73 % Of Sales - 1.77% 1.46% 1.46% 0.97% 1.11% 1.50% 1.06% 0.84% 0.87% 0.78% Employee Cost - 121.50 99.42 82.59 72.54 65.06 58.61 44.02 33.85 26.29 25.03 % Of Sales - 16.65% 14.90% 13.64% 12.12% 10.22% 12.59% 9.96% 7.94% 8.83% 7.19% Manufacturing Exp. - 20.05 15.50 17.25 11.09 10.91 7.13 5.97 4.24 3.64 3.31 % Of Sales - 2.75% 2.32% 2.85% 1.85% 1.71% 1.53% 1.35% 0.99% 1.22% 0.95% General & Admin Exp. - 20.81 15.31 11.61 10.88 12.00 8.70 10.33 13.71 11.11 11.73 % Of Sales - 2.85% 2.29% 1.92% 1.82% 1.89% 1.87% 2.34% 3.21% 3.73% 3.37% Selling & Distn. Exp. - 58.48 62.92 55.12 56.50 55.70 28.56 26.16 31.07 14.77 26.29 % Of Sales - 8.01% 9.43% 9.10% 9.44% 8.75% 6.14% 5.92% 7.28% 4.96% 7.55% Miscellaneous Exp. - 34.15 26.61 23.44 36.48 32.45 10.76 13.88 21.91 5.22 26.29 % Of Sales - 4.68% 3.99% 3.87% 6.10% 5.10% 2.31% 3.14% 5.14% 1.75% 3.21% EBITDA 183.31 119.23 91.58 107.17 90.16 109.20 91.46 100.17 93.10 88.46 100.53 EBITDA Margin 21.34% 16.34% 13.73% 17.70% 15.07% 17.16% 19.65% 22.67% 21.82% 29.70% 28.89% Other Income 35.73 58.52 36.22 33.50 50.77 32.63 19.41 37.00 35.81 10.99 9.08 Interest 4.80 11.11 6.58 5.81 10.06 4.32 5.92 6.62 3.15 6.95 9.07 Depreciation 34.14 31.02 27.05 23.52 15.17 13.85 13.76 8.83 5.75 5.67 5.62 PBT 219.02 135.62 94.17 111.34 115.69 123.66 91.19 121.71 120.01 86.84 94.91 Tax 55.80 36.59 25.20 19.61 30.21 33.74 23.69 29.38 45.58 29.82 35.77 Tax Rate 25.48% 27.42% 26.76% 27.91% 26.11% 26.69% 25.98% 24.14% 37.98% 34.34% 37.69% PAT 163.21 96.87 68.97 50.64 85.48 92.66 67.50 92.33 74.43 57.01 59.13 PAT before Minority Interest 163.21 96.87 68.97 50.64 85.48 92.66 67.50 92.33 74.43 57.01 59.13 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.00% 13.27% 10.34% 8.36% 14.29% 14.56% 14.50% 20.89% 17.45% 19.14% 16.99% PAT Growth 108.34% 40.45% 36.20% -40.76% -7.75% 37.27% -26.89% 24.05% 30.56% -3.59% EPS 15.35 9.11 6.49 4.76 8.04 8.72 6.35 8.69 7.00 5.36 5.56

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,074.19 927.11 809.73 770.24 751.59 747.45 577.21 689.31 898.57 814.64 798.44 Net Sales Growth 24.87% 14.50% 5.13% 2.48% 0.55% 29.49% -16.26% -23.29% 10.30% 2.03% Cost Of Goods Sold 449.02 425.07 413.69 382.11 401.32 390.98 329.71 439.97 612.26 391.13 358.93 Gross Profit 625.17 502.05 396.04 388.13 350.26 356.47 247.49 249.34 286.31 423.52 439.51 GP Margin 58.20% 54.15% 48.91% 50.39% 46.60% 47.69% 42.88% 36.17% 31.86% 51.99% 55.05% Total Expenditure 837.97 777.88 683.04 619.62 634.26 629.11 470.56 565.99 740.93 617.50 595.70 Power & Fuel Cost - 14.23 11.33 10.43 7.13 8.25 8.14 5.88 4.76 5.49 5.58 % Of Sales - 1.53% 1.40% 1.35% 0.95% 1.10% 1.41% 0.85% 0.53% 0.67% 0.70% Employee Cost - 136.43 112.05 95.58 86.17 76.15 68.09 53.69 42.32 69.23 61.35 % Of Sales - 14.72% 13.84% 12.41% 11.47% 10.19% 11.80% 7.79% 4.71% 8.50% 7.68% Manufacturing Exp. - 22.74 16.83 18.59 12.24 12.09 7.83 7.07 4.95 4.88 5.39 % Of Sales - 2.45% 2.08% 2.41% 1.63% 1.62% 1.36% 1.03% 0.55% 0.60% 0.68% General & Admin Exp. - 27.58 20.73 17.48 16.50 15.03 12.03 13.27 17.05 39.48 36.36 % Of Sales - 2.97% 2.56% 2.27% 2.20% 2.01% 2.08% 1.93% 1.90% 4.85% 4.55% Selling & Distn. Exp. - 93.97 73.58 68.41 63.95 67.18 31.35 28.83 34.72 62.09 92.46 % Of Sales - 10.14% 9.09% 8.88% 8.51% 8.99% 5.43% 4.18% 3.86% 7.62% 11.58% Miscellaneous Exp. - 57.86 34.84 27.02 46.96 59.43 13.40 17.28 24.86 45.21 92.46 % Of Sales - 6.24% 4.30% 3.51% 6.25% 7.95% 2.32% 2.51% 2.77% 5.55% 4.46% EBITDA 236.21 149.23 126.69 150.62 117.33 118.34 106.65 123.32 157.64 197.14 202.74 EBITDA Margin 21.99% 16.10% 15.65% 19.55% 15.61% 15.83% 18.48% 17.89% 17.54% 24.20% 25.39% Other Income 47.52 88.33 36.49 28.74 17.79 31.49 21.95 39.19 37.63 26.54 12.51 Interest 7.38 12.01 8.12 6.91 10.36 4.74 7.24 7.57 4.41 22.80 19.69 Depreciation 37.46 33.48 29.42 26.38 18.67 17.33 17.23 12.59 8.94 21.38 20.14 PBT 236.42 192.08 125.64 146.07 106.07 127.76 104.13 142.35 181.92 179.49 175.40 Tax 69.94 54.86 35.38 35.29 29.34 31.04 30.16 33.71 55.25 56.63 62.72 Tax Rate 29.58% 28.94% 28.16% 30.20% 27.66% 57.30% 28.96% 26.14% 30.37% 38.98% 35.76% PAT 166.49 129.13 84.30 75.46 70.85 15.04 68.49 97.26 123.72 58.78 82.04 PAT before Minority Interest 161.20 134.73 90.26 81.58 76.73 23.13 73.97 95.25 126.66 88.66 112.68 Minority Interest -5.29 -5.60 -5.96 -6.12 -5.88 -8.09 -5.48 2.01 -2.94 -29.88 -30.64 PAT Margin 15.50% 13.93% 10.41% 9.80% 9.43% 2.01% 11.87% 14.11% 13.77% 7.22% 10.28% PAT Growth 44.27% 53.18% 11.71% 6.51% 371.08% -78.04% -29.58% -21.39% 110.48% -28.35% EPS 15.66 12.15 7.93 7.10 6.67 1.41 6.44 9.15 11.64 5.53 7.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,155.19 1,058.63 988.44 937.00 851.43 755.65 682.94 603.27 541.42 491.64 Share Capital 10.58 10.54 10.47 10.42 10.37 10.31 10.31 10.31 10.31 10.31 Total Reserves 1,132.95 1,041.80 970.25 917.69 831.12 735.50 672.63 592.96 531.11 481.33 Non-Current Liabilities 5.30 27.42 42.82 49.34 35.71 43.87 46.66 40.60 15.73 22.84 Secured Loans 0.00 19.67 35.10 40.69 23.22 32.49 35.55 30.53 5.55 12.47 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.00 4.36 2.60 2.61 1.07 2.50 2.44 1.75 1.91 1.81 Current Liabilities 168.59 125.00 114.89 153.36 192.83 146.11 125.50 91.98 136.85 151.82 Trade Payables 96.26 60.32 54.47 75.87 84.21 66.78 55.95 30.87 35.34 63.80 Other Current Liabilities 63.61 60.77 49.15 50.72 62.46 42.36 32.75 23.47 11.81 11.84 Short Term Borrowings 0.00 3.42 10.74 25.02 41.47 35.38 35.94 36.64 82.53 61.50 Short Term Provisions 8.72 0.49 0.54 1.74 4.69 1.59 0.87 1.01 7.18 14.68 Total Liabilities 1,329.08 1,211.05 1,146.15 1,139.70 1,079.97 945.63 855.10 735.85 694.00 666.30 Net Block 419.54 367.89 329.95 324.82 224.31 174.10 178.86 78.32 72.48 75.34 Gross Block 554.54 477.72 413.45 385.02 269.54 210.93 202.33 93.44 83.40 80.85 Accumulated Depreciation 135.00 109.84 83.50 60.21 45.22 36.84 23.47 15.12 10.92 5.51 Non Current Assets 502.72 445.31 373.92 410.04 288.22 268.98 212.46 157.95 117.72 111.50 Capital Work in Progress 4.40 20.58 7.83 2.80 22.15 2.39 0.00 42.91 0.47 1.98 Non Current Investment 18.69 18.69 18.69 18.26 18.26 18.30 19.00 19.01 19.17 21.54 Long Term Loans & Adv. 28.10 18.63 14.27 17.18 22.44 11.35 13.36 17.38 25.31 12.23 Other Non Current Assets 31.31 18.84 2.50 46.30 0.37 62.15 1.24 0.33 0.29 0.42 Current Assets 826.36 765.74 772.23 729.65 791.74 676.64 642.65 577.90 576.29 554.80 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 110.92 81.94 89.45 74.15 90.11 83.68 60.57 54.84 39.80 28.06 Sundry Debtors 457.12 428.70 399.51 399.06 408.82 348.68 404.91 342.09 282.54 239.41 Cash & Bank 110.60 171.11 169.32 84.61 149.48 119.52 86.62 93.29 70.29 83.57 Other Current Assets 147.73 24.59 25.74 14.15 143.32 124.76 90.55 87.68 183.65 203.76 Short Term Loans & Adv. 120.80 59.40 88.22 157.68 126.55 101.48 74.25 62.40 143.27 173.39 Net Current Assets 657.77 640.74 657.34 576.30 598.91 530.54 517.15 485.92 439.44 402.98 Total Assets 1,329.08 1,211.05 1,146.15 1,139.69 1,079.96 945.62 855.11 735.85 694.01 666.30

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,192.90 1,050.38 967.19 883.90 818.70 808.25 735.61 646.00 536.24 486.62 Share Capital 10.58 10.54 10.47 10.42 10.37 10.31 10.31 10.31 10.31 10.31 Total Reserves 1,170.66 1,033.54 949.00 864.59 798.40 788.10 725.30 635.68 525.92 476.31 Non-Current Liabilities 8.81 37.28 51.20 42.84 29.20 45.24 46.32 37.99 12.92 32.81 Secured Loans 0.00 19.85 35.59 40.69 23.22 32.60 37.24 32.54 5.92 25.58 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.41 4.36 2.67 2.69 1.07 2.50 2.44 1.75 1.91 2.05 Current Liabilities 235.54 172.16 157.41 193.26 233.09 203.64 230.53 207.03 299.40 437.09 Trade Payables 104.21 71.42 60.97 86.39 92.61 74.22 89.92 78.88 58.43 98.25 Other Current Liabilities 93.83 73.44 62.46 58.20 67.85 53.69 57.21 50.24 124.46 99.93 Short Term Borrowings 2.75 22.89 32.12 46.01 60.70 65.04 66.39 64.30 105.66 187.47 Short Term Provisions 34.75 4.42 1.87 2.66 11.93 10.69 17.01 13.61 10.85 51.45 Total Liabilities 1,476.11 1,301.29 1,211.59 1,153.53 1,108.75 1,076.79 1,027.22 904.88 860.04 1,022.90 Net Block 458.61 404.95 369.37 378.05 280.76 233.72 240.97 144.97 136.48 303.86 Gross Block 607.42 531.06 467.78 458.74 343.41 285.10 276.07 169.89 157.47 326.83 Accumulated Depreciation 148.82 126.11 98.41 80.69 62.65 51.38 35.10 24.92 20.99 22.97 Non Current Assets 529.78 477.46 400.72 456.15 331.89 311.59 257.48 211.39 170.25 456.97 Capital Work in Progress 6.05 20.71 7.83 2.80 22.15 2.39 0.00 46.74 0.47 4.03 Non Current Investment 3.52 4.38 3.61 2.84 2.39 0.01 0.72 0.72 6.30 1.05 Long Term Loans & Adv. 29.54 19.77 14.72 17.62 24.42 12.63 14.56 18.63 26.72 11.45 Other Non Current Assets 31.38 26.96 4.50 54.16 1.47 62.15 1.24 0.33 0.29 136.58 Current Assets 946.34 816.66 810.87 697.37 776.86 765.20 769.74 693.49 689.79 565.93 Current Investments 1.45 0.00 0.56 4.96 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 150.73 125.73 118.45 103.06 123.94 98.93 74.14 77.37 59.03 49.30 Sundry Debtors 517.19 438.80 404.35 385.17 392.75 463.82 547.91 460.73 298.48 254.45 Cash & Bank 166.87 213.31 215.62 102.99 177.53 144.55 103.32 106.63 88.86 150.50 Other Current Assets 110.10 14.67 17.01 6.63 82.64 57.90 44.37 48.76 243.41 111.68 Short Term Loans & Adv. 96.40 24.15 54.90 94.56 68.52 40.35 28.24 22.55 146.30 78.44 Net Current Assets 710.79 644.49 653.47 504.11 543.77 561.56 539.21 486.47 390.39 128.84 Total Assets 1,476.12 1,294.12 1,211.59 1,153.52 1,108.75 1,076.79 1,027.22 904.88 860.04 1,022.90

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 123.16 97.21 82.17 43.81 114.05 66.97 63.22 48.29 22.67 38.48 PBT 133.46 94.17 111.34 115.69 123.66 91.19 121.71 120.01 86.84 94.91 Adjustment 70.33 56.44 44.25 41.42 35.10 41.14 3.43 3.36 0.77 28.12 Changes in Working Capital -42.18 -23.08 -44.08 -75.58 -14.23 -42.64 -30.07 -25.53 -29.06 -47.37 Cash after chg. in Working capital 161.61 127.53 111.51 81.53 144.52 89.69 95.08 97.84 58.54 75.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -38.46 -30.33 -29.34 -37.72 -30.47 -22.72 -31.86 -49.55 -35.87 -37.17 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -51.40 -77.87 -65.84 -12.97 -92.28 -61.62 -60.14 -68.04 16.36 -29.34 Net Fixed Assets -60.64 -77.02 -33.46 -96.13 -78.37 -10.99 -65.98 -52.48 -1.04 42.08 Net Investments 0.00 0.00 -0.43 0.00 0.04 0.70 0.01 0.16 2.37 -0.95 Others 9.24 -0.85 -31.95 83.16 -13.95 -51.33 5.83 -15.72 15.03 -70.47 Cash from Financing Activity -75.37 -26.56 -20.76 -26.05 -12.62 -11.67 -5.83 9.05 -21.91 -14.77 Net Cash Inflow / Outflow -3.61 -7.23 -4.43 4.79 9.14 -6.33 -2.75 -10.70 17.12 -5.63 Opening Cash & Equivalents 6.85 14.17 18.60 13.82 4.67 11.00 13.75 24.45 7.33 12.95 Closing Cash & Equivalent 3.33 6.85 14.17 18.60 13.82 4.67 11.00 13.75 24.45 7.33

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 138.72 105.91 102.82 34.31 135.48 63.97 46.70 39.95 17.64 289.47 PBT 189.59 125.64 146.07 106.07 127.76 104.13 128.97 181.91 179.49 175.40 Adjustment 95.87 70.75 38.17 57.92 -31.71 46.29 26.85 -10.97 17.55 36.24 Changes in Working Capital -104.45 -51.46 -46.57 -85.12 73.37 -57.89 -70.32 -183.07 -140.80 113.48 Cash after chg. in Working capital 181.01 144.93 137.67 78.87 169.42 92.53 85.49 -12.13 56.24 325.13 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -41.65 -36.64 -34.85 -44.56 -33.94 -28.56 -38.79 52.08 -38.61 -35.66 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -0.64 -2.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -38.28 -75.59 -83.19 -7.75 -92.98 -46.99 -47.89 -73.52 50.24 -231.25 Net Fixed Assets -60.64 -77.02 -33.46 -96.13 -78.37 -10.99 -65.98 -52.48 -1.04 42.08 Net Investments 0.00 0.00 -0.43 0.00 0.04 0.70 0.01 0.16 2.37 -0.95 Others 22.36 1.43 -49.30 88.38 -14.65 -36.70 18.08 -21.20 48.91 -272.38 Cash from Financing Activity -89.21 -30.20 -20.89 -24.94 -23.73 -20.80 -6.30 16.83 -75.98 -10.13 Net Cash Inflow / Outflow 11.23 0.13 -1.27 1.62 18.78 -3.82 -7.50 -16.74 -8.10 48.09 Opening Cash & Equivalents 23.82 23.59 25.01 21.99 13.13 15.34 15.04 36.95 47.41 0.00 Closing Cash & Equivalent 35.14 23.82 23.59 25.01 21.99 13.13 15.34 15.04 36.95 47.41

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 108.10 99.87 93.68 89.11 81.16 72.31 66.21 58.49 52.49 47.66 ROA 7.63% 5.85% 4.43% 7.70% 9.15% 7.50% 11.61% 10.41% 8.38% 8.67% ROE 8.82% 6.78% 5.31% 9.66% 11.68% 9.45% 14.36% 13.00% 11.04% 12.80% ROCE 12.77% 9.31% 7.36% 12.89% 14.68% 12.02% 17.75% 18.80% 15.60% 19.25% Fixed Asset Turnover 1.50 1.57 1.52 1.83 2.65 2.25 2.99 4.82 3.63 3.44 Receivable days 209.20 215.90 240.71 246.41 217.24 295.44 308.46 267.22 319.34 255.29 Inventory Days 45.55 44.68 49.31 50.10 49.84 56.55 47.66 40.49 41.51 26.05 Payable days 83.40 60.52 79.43 92.78 80.11 88.42 48.84 39.16 90.96 75.73 Cash Conversion Cycle 171.35 200.06 210.59 203.74 186.97 263.57 307.29 268.56 269.89 205.62 Total Debt/Equity 0.00 0.05 0.07 0.08 0.10 0.12 0.13 0.12 0.17 0.15 Interest Cover 13.01 15.30 13.10 12.50 30.23 16.40 19.38 39.08 13.49 11.46

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 111.66 99.09 91.65 84.01 78.01 77.41 71.32 62.63 51.99 47.18 ROA 9.70% 7.18% 6.90% 6.78% 2.12% 7.03% 9.86% 14.35% 9.42% 11.88% ROE 12.11% 9.01% 8.89% 9.11% 2.88% 9.64% 13.79% 21.43% 17.34% 25.06% ROCE 17.40% 12.29% 12.15% 12.22% 6.37% 12.49% 17.02% 26.58% 24.61% 31.06% Fixed Asset Turnover 1.70 1.69 1.66 1.87 2.38 2.06 3.09 5.49 3.37 2.56 Receivable days 180.13 182.64 187.07 188.89 209.14 319.89 267.05 154.20 123.80 126.33 Inventory Days 52.09 52.89 52.48 55.12 54.42 54.72 40.11 27.70 24.25 20.01 Payable days 75.40 58.40 70.38 81.40 77.87 90.85 56.62 35.01 51.74 67.63 Cash Conversion Cycle 156.82 177.13 169.17 162.62 185.69 283.75 250.53 146.89 96.31 78.70 Total Debt/Equity 0.00 0.07 0.09 0.11 0.13 0.15 0.16 0.16 0.22 0.46 Interest Cover 16.79 16.47 17.91 11.23 12.42 15.38 18.04 42.21 7.37 9.91

Top Investors:

clarus capital i

investor education and protection fund authority ministry of corporate affairs

360 one pipe fund

coeus global opportunities fund

life insurance corporation of india

gee bee securities private limited

amit ashok thawani

Annual Reports:

News Update:

Bliss GVS Pharma - Quarterly Results
30th Oct 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback